In this study, we clarified the dynamics of Mdmx after cerebral ischemia, and demonstrated the neuroprotective effects of our newly developed small-molecule PPI inhibitors by modifying the interactions between Mdmx and p53 and HDAC6 activity inhibition. The gene discussed is TP53; the disease is brain ischemia.